US Patent Issued to UNIVERSITY OF SOUTH FLORIDA on May 19 for "Engineered lysin-human defensin protein" (Florida Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,596, issued on May 19, was assigned to UNIVERSITY OF SOUTH FLORIDA (Tampa, Fla.).

"Engineered lysin-human defensin protein" was invented by Xingmin Sun (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Clostridium difficile, reclassified as Clostridioides difficile, is a Gram-positive, spore-forming, anaerobic, and toxin-producing nosocomial pathogen. Since the first description of a C. difficile-associated disease (CDAD)-like case in 1892, C. difficile infection (CDI) has become a high-impact health care-associated infection throughout the world, especially in the developed countries. Described herein are methods of treating Clostridium di...